S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

$17.25
-0.13 (-0.75%)
(As of 04/16/2024 ET)
Today's Range
$16.89
$17.33
50-Day Range
$14.11
$17.89
52-Week Range
$13.82
$27.94
Volume
444,277 shs
Average Volume
470,398 shs
Market Capitalization
$808.34 million
P/E Ratio
20.06
Dividend Yield
0.23%
Price Target
$18.50

Core Laboratories MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
7.2% Upside
$18.50 Price Target
Short Interest
Bearish
14.19% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.11mentions of Core Laboratories in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
35.80%
From $0.81 to $1.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.10 out of 5 stars

Oils/Energy Sector

210th out of 238 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

15th out of 18 stocks

CLB stock logo

About Core Laboratories Stock (NYSE:CLB)

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

CLB Stock Price History

CLB Stock News Headlines

Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
Q4 2023 Evoke Pharma Inc Earnings Call
Core Laboratories (CLB) Fell on Mixed Earnings Results
Core Laboratories (CLB) Fell Due to Weak US Land Drilling
CLB Dec 2024 10.000 put
CLB Mar 2024 20.000 put
Q4 2023 Core Laboratories Inc Earnings Call
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 3/4 Dividend
2/09/2024
Dividend Payable
3/04/2024
Today
4/16/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Target
$18.50
High Stock Price Target
$21.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+7.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$36.67 million
Pretax Margin
8.08%

Debt

Sales & Book Value

Annual Sales
$509.79 million
Cash Flow
$1.05 per share
Book Value
$4.92 per share

Miscellaneous

Free Float
46,508,000
Market Cap
$808.34 million
Optionable
Optionable
Beta
2.40

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Lawrence V. Bruno (Age 63)
    Chairman of the Board, CEO, President & COO
    Comp: $1.47M
  • Mr. Christopher Scott Hill (Age 54)
    Senior VP & CFO
    Comp: $668.8k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 56)
    Senior Vice President of Corporate Development & Investor Relations
    Comp: $574.19k
  • Mr. Mark Damian Tattoli (Age 52)
    Senior VP, Secretary & General Counsel
    Comp: $565.11k
  • Mr. Kevin G. Daniels (Age 60)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 69)
    Managing Director
    Comp: $26.35k
  • J. Donald Dumas Jr.
    Senior VP of Production Enhancement & Business Development

CLB Stock Analysis - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price target for 2024?

4 Wall Street analysts have issued 12-month target prices for Core Laboratories' shares. Their CLB share price targets range from $16.00 to $21.00. On average, they anticipate the company's stock price to reach $18.50 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2024?

Core Laboratories' stock was trading at $17.66 on January 1st, 2024. Since then, CLB shares have decreased by 2.3% and is now trading at $17.25.
View the best growth stocks for 2024 here
.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 6,590,000 shares, an increase of 10.0% from the March 15th total of 5,990,000 shares. Based on an average trading volume of 474,000 shares, the days-to-cover ratio is currently 13.9 days. Approximately 14.2% of the company's stock are sold short.
View Core Laboratories' Short Interest
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CLB earnings forecast
.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) posted its quarterly earnings results on Wednesday, January, 31st. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.01. The oil and gas company earned $128.21 million during the quarter, compared to the consensus estimate of $127.80 million. Core Laboratories had a trailing twelve-month return on equity of 15.19% and a net margin of 8.03%. During the same period in the previous year, the business earned $0.23 earnings per share.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Wednesday, January 31st. Investors of record on Monday, February 12th will be given a dividend of $0.01 per share on Monday, March 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Friday, February 9th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.23%. The dividend payout ratio is 4.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.64% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its first quarter earnings guidance on Wednesday, January, 31st. The company provided EPS guidance of $0.14-0.18 for the period, compared to the consensus EPS estimate of $0.17. The company issued revenue guidance of $122-128 million, compared to the consensus revenue estimate of $126.23 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Congress Asset Management Co. MA (3.43%), Confluence Investment Management LLC (0.31%), Partnership Wealth Management LLC (0.27%), Ridgewood Investments LLC (0.07%), CWM LLC (0.01%) and GAMMA Investing LLC (0.01%).
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CLB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners